mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.01 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |